Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 18/20 | 0.86 |
| ▸ | CYP21A2 | P08686 | 18/20 | 0.86 |
| ▸ | CYP11B1 | P15538 | 16/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.86 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.86 |
| ▸ | CYP7A1 | P22680 | 1/20 | 0.86 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.60 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.60 |
| ▸ | CYP27B1 | O15528 | 1/20 | 0.60 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.60 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.60 |
| ▸ | GMNN | O75496 | 1/20 | 0.60 |
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16608565 | 1.00 | CYP17A1 (0.86) | CYP17A1CYP21A2CYP11B1CYP3A4CYP19A1 | |
| SCHEMBL16600061 | 1.00 | CYP17A1 (0.86) | CYP17A1CYP21A2CYP11B1CYP3A4CYP19A1 | |
| SCHEMBL16608239 | 0.93 | CYP21A2 (1.00) | CYP17A1CYP21A2CYP11B1CYP3A4CYP19A1 | |
| SCHEMBL16599798 | 0.93 | CYP21A2 (1.00) | CYP17A1CYP21A2CYP11B1CYP3A4CYP19A1 | |
| SCHEMBL16599796 | 0.93 | CYP21A2 (1.00) | CYP17A1CYP21A2CYP11B1CYP3A4CYP19A1 | |
| SCHEMBL16599839 | 0.91 | CYP17A1 (1.00) | CYP17A1CYP21A2CYP11B1CYP3A4CYP19A1 | |
| SCHEMBL16608508 | 0.91 | CYP17A1 (1.00) | CYP17A1CYP21A2CYP11B1CYP3A4CYP19A1 | |
| SCHEMBL16599841 | 0.91 | CYP17A1 (1.00) | CYP17A1CYP21A2CYP11B1CYP3A4CYP19A1 | |
| SCHEMBL16600117 | 0.86 | CYP17A1 (1.00) | CYP17A1CYP21A2CYP11B1CYP3A4CYP19A1 | |
| SCHEMBL16608216 | 0.86 | CYP17A1 (1.00) | CYP17A1CYP21A2CYP11B1CYP3A4CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160244436-A1 | NOVEL FUNCTIONALIZED 5-(PHENOXYMETHYL)-1,3-DIOXANE ANALOGS EXHIBITING CYTOCHROME P450 INHIBITION AND THEIR METHOD OF USE | CORTENDO AB (PUBL) | 2016-08-25 | — | — | US | disclosed |
| EP-3049084-A1 | NOVEL FUNCTIONALIZED 5-(PHENOXYMETHYL)-1,3-DIOXANE ANALOGS EXHIBITNG CYTOCHROME P450 INHIBITION | Cortendo AB (publ) (US) | 2016-08-03 | — | — | EP | disclosed |
| WO-2015048311-A1 | NOVEL FUNCTIONALIZED 5-(PHENOXYMETHYL)-1,3-DIOXANE ANALOGS EXHIBITNG CYTOCHROME P450 INHIBITION | CORTENDO AB (PUBL) (US) | 2015-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160244436-A1 | NOVEL FUNCTIONALIZED 5-(PHENOXYMETHYL)-1,3-DIOXANE ANALOGS EXHIBITING CYTOCHROME P450 INHIBITION AND THEIR METHOD OF USE | CYP11B1, CYP11B2, CYP21A2 | CYP17A1 4/4885CYP21A2 3/4885CYP11B1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.